Quick Answer
Fulgent Genetics, Inc. reported Gross Profit of $130.88 million for fiscal year 2025.
Fulgent Genetics, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $130.88M | +22.1% |
| 2024 | $107.22M | +2.6% |
| 2023 | $104.46M | -71.5% |
| 2022 | $366.90M | -52.8% |
| 2021 | $777.05M | +134.1% |
| 2020 | $331.90M | +1701.8% |
| 2019 | $18.42M | +72.9% |
| 2018 | $10.65M | +4.7% |
| 2017 | $10.18M | -11.9% |
| 2016 | $11.55M | +156.4% |
| 2015 | $4.51M | +1217.8% |
| 2014 | $342.0K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $35.51M | +32.7% | +3.1% |
| June 30, 2025 | $34.44M | +30.0% | +21.5% |
| March 31, 2025 | $28.35M | +28.2% | +5.9% |
| September 30, 2024 | $26.77M | -32.8% | +1.1% |
| June 30, 2024 | $26.49M | +28.8% | +19.8% |
| March 31, 2024 | $22.10M | +17.5% | -44.5% |
| September 30, 2023 | $39.84M | -13.6% | +93.7% |
| June 30, 2023 | $20.57M | -68.5% | +9.4% |
- Fulgent Genetics, Inc. showed an increase of +22.1% in Gross Profit compared to the prior fiscal year.
- Over the 2014–2025 period, Fulgent Genetics, Inc.’s gross profit has grown by 38167.5% (from $342.0 thousand to $130.88 million).
- The most recent figure is from Fulgent Genetics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: